Alexion Pharmaceuticals Stock Price and Value Analysis

Should you buy Alexion Pharmaceuticals stock? (NasdaqGS:ALXN). Let's see how it does in our automated value investing analysis system.

  • This company has wild ups and downs.
  • This company is not making money.
  • This company is less known than others.
  • This stock looks overpriced.
  • This company pays no dividend.

ALXN Free Cash Flow Trend

Hmm, we can't give any reliable projection for Alexion Pharmaceuticals's growth rate. The company either has too few years of historical data for us to examine, or it's in the habit of losing money.

None of this means it's a bad stock. Maybe it's new and growing quickly, or maybe it's turning things around. We can't say anything sensible about it, so we won't say it's obviously undervalued right now. Proceed at your own risk!

Free Cash Flow trendline for ALXN
Free Cash Flow trendline for Alexion Pharmaceuticals

Inside the ALXN Numbers

ALXN Price
(Alexion Pharmaceuticals stock price per share)
[?] PE Ratio versus Sector 162% higher than other Healthcare stocks
[?] PE Ratio versus Industry 57.8% higher than other Biotechnology stocks
[?] Cash Yield 2.02%
[?] Free Cash Flow Jitter 95%

Is Alexion Pharmaceuticals Stock on Sale?

Based on our analysis, we believe that you should not buy Alexion Pharmaceuticals right now. It might be a good stock to own—we just can't prove it with value analysis right now. Proceed with caution.

Should You Buy ALXN Stock?

Does Alexion Pharmaceuticals have a coherent story? Does it have a plan to continue to make money? Is it worth your time? Only you can decide where to go from here. Our investment guide helps you ask the right questions, including how to buy stocks. Use these research links for more information.